Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 13, 2018
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter StudyCatherine C Bell, Anita C A Dankers, Volker M Lauschke, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injuryChristopher Goldring, Daniel J Antoine, Frank Bonner, et al.
International Journal of Cancer|February 21, 2003
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controlsPaolo Vineis, Fabrizio Veglia, Simone Benhamou, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Archives of Toxicology|June 27, 2016
A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicityRowena L Sison-Young, Volker M Lauschke, Esther Johann, et al.
Nature Reviews. Drug Discovery|November 22, 2019
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive modelsRichard J Weaver, Eric A Blomme, Amy E Chadwick, et al.
Pharmacogenetics and Genomics|April 23, 2020
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.
Mutation Research|July 13, 2005
Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC studySara Raimondi, Paolo Boffetta, Sisko Anttila, et al.
Carcinogenesis|August 2, 2002
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer riskSimone Benhamou, Won Jin Lee, Anna-Karin Alexandrie, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 13, 2018
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter StudyCatherine C Bell, Anita C A Dankers, Volker M Lauschke, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injuryChristopher Goldring, Daniel J Antoine, Frank Bonner, et al.
International Journal of Cancer|February 21, 2003
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controlsPaolo Vineis, Fabrizio Veglia, Simone Benhamou, et al.
Pharmacogenomics|April 4, 2023
The Sixth European Society of Pharmacogenomics and Personalised Therapy CongressRon Hn van Schaik, Vangelis G Manolopoulos, Ann K Daly, et al.
Archives of Toxicology|June 27, 2016
A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicityRowena L Sison-Young, Volker M Lauschke, Esther Johann, et al.
Nature Reviews. Drug Discovery|November 22, 2019
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive modelsRichard J Weaver, Eric A Blomme, Amy E Chadwick, et al.
Pharmacogenetics and Genomics|April 23, 2020
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.
Mutation Research|July 13, 2005
Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC studySara Raimondi, Paolo Boffetta, Sisko Anttila, et al.
Carcinogenesis|August 2, 2002
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer riskSimone Benhamou, Won Jin Lee, Anna-Karin Alexandrie, et al.
Pageof 27